Analysis of growth in children with ADHD during long-term therapy with once-daily OROS® methylphenidate

被引：0

作者：

Lerner, MA

Spencer, T

机构：

[1] Univ Calif Irvine, Irvine, CA 92717 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

PEDIATRIC RESEARCH | 2004年 / 55卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：1A / 1A

页数：1

共 50 条

[31] ONCE-DAILY MORNING IMMUNOSUPPRESSION: A SOLUTION TO LONG-TERM TREATMENT ADHERENCE
Garandeau, C.
Figueres, L.
Houzet, A.
Ville, S.
Dantal, J.
Giral, M.
Blancho, G.
Hourmant, M.
Cantarovich, D.
TRANSPLANT INTERNATIONAL, 2020, 33 : 13 - 13
[32] Treatment of children with attention-deficit/hyperactivity disorder for up to one year with the once-daily OROS formulation of methylphenidate: Safety and efficacy
Santosh, P
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S452 - S452
[33] Advances in the long-term management of chronic pain:: Recent evidence with OROS® hydromorphone, a novel, once-daily, long-acting opioid analgesic -: Introduction
Cousins, Michael J.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 33 (02) : S1 - S3
[34] Long-term safety and effectiveness of Concerta (Methylphenidate HCI) in children with ADHD
Wilens, TE
NEUROLOGY, 2000, 54 (07) : A420 - A420
[35] LONG-TERM BENEFIT OF CARDIOSELECTIVE BETA BLOCKADE WITH ONCE-DAILY ATENOLOL THERAPY IN ANGINA-PECTORIS
SCHWARTZ, JB
JACKSON, G
KATES, RE
HARRISON, DC
AMERICAN HEART JOURNAL, 1981, 101 (04) : 380 - 385
[36] Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation
Antoniou, Sotiris
Amara, Walid
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0D) : D7 - D15
[37] SCHOOL CHILDREN WITH ADHD - EFFECTS OF ONCE-DEALY OROS METHYLPHENIDATE TREATMENT ADHD SYMPTOMS INCLUDED IMPROVEMENT ACADEMIC FUNCTIONING
Djurkovic-Lazic, J.
Lazic, B.
Milojevic, N.
Djuric, D.
EUROPEAN PSYCHIATRY, 2009, 24
[38] Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth
Faraone, Stephen V.
Giefer, Eldred E.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (09): : 1138 - 1147
[39] An observational study of once-daily modified-release methylphenidate in ADHD: Effectiveness on symptoms and impairment, and safety
Döpfner M.
Görtz-Dorten A.
Breuer D.
Rothenberger A.
European Child & Adolescent Psychiatry, 2011, 20 (Suppl 2) : S243 - S255
[40] SOTALOL IN MILD TO SEVERE HYPERTENSION - TWICE-DAILY AND ONCE-DAILY ADMINISTRATION - LONG-TERM STUDY
REYNAERT, J
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 26 (06): : 799 - 812

← 1 2 3 4 5 →